Abstract
Abstract
Background
Cardiovascular events such as myocardial infarction and stroke are life-threatening complications associated with Neurofibromatosis type 1 (NF1). As previous studies observed an association between cardiovascular events and the loss of circadian variations of blood pressure, we investigated the 24 h circadian rhythm of blood pressure (BP) in 24 NF1 patients (10 males and 14 females, with a mean age of 39.5 years ± 14 years) by using ambulatory blood pressure monitoring (ABPM).
Results
Only one-third of the patient were dippers, 50% were non-dippers, and 17% were risers. Reduced variability of systolic and diastolic nocturnal blood pressure was observed in NF1 patients compared with several studies of normotensive individuals (p = 0.024). In NF1 patients, the blunted systolic nocturnal decline was significantly associated with the number of neurofibromas (p = 0.049) and the presence of a plexiform neurofibroma (p = 0.020).
Conclusions
Most NF1 patients in this study showed a “non-dipper” pattern with a blunted nocturnal BP decline, which is considered an independent risk factor for cardiovascular events in normotensive and hypertensive individuals. Periodic monitoring of BP should be included in NF1 follow-up guidelines to diagnose masked hypertension or a non-dipper/riser pattern which would significantly increase the morbidity and mortality of NF1 patients to implement therapeutic strategies.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Genetics (clinical),General Medicine
Reference51 articles.
1. Zoller M, Rembeck B, Akesson HO, Angervall L. Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Goteborg, Sweden. Acta Derm Venereol. 1995;75(2):136–40.
2. Friedman DHG, Mia, MacCollin. Neurofibromatosis: phenotype, natural history and pathogenesis. Neurology. 2000;55:325.
3. Faris M, Baliss M, Coni R, Nambudiri V. Severe hypertension leading to hemorrhagic stroke in neurofibromatosis type 1. Cureus. 2021;13(4):e14658.
4. Guthrie GP Jr, Tibbs PA, McAllister RG Jr, Stevens RK, Clark DB. Hypertension and neurofibromatosis. Case report. Hypertension. 1982;4(6):894–7.
5. Currarino MHaG. Vascular lesions causing hypertension in neurofibromatosis. N Engl J Med. 1965;273:248–52.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献